Capital International Investors Sarepta Therapeutics, Inc. Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital International Investors holds 9,060,772 shares of SRPT stock, worth $155 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
9,060,772
Previous 8,697,137
4.18%
Holding current value
$155 Million
Previous $1.06 Billion
45.32%
% of portfolio
0.12%
Previous 0.21%
Shares
11 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$177 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$69.6 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$57.6 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$45.8 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.5B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...